RUNX1 Regulates Site Specificity of DNA Demethylation by Recruitment of DNA Demethylation Machineries in Hematopoietic Cells

Overview

Journal Blood Adv

Specialty Hematology

Date 2018 Jan 4

PMID 29296817

Citations 46

Authors

Takahiro Suzuki

Yuri Shimizu

Erina Furuhata

Shiori Maeda

Mami Kishima

Hajime Nishimura

Saaya Enomoto

Yoshihide Hayashizaki

Harukazu Suzuki

Affiliations

Soon will be listed here.

Abstract

RUNX1 is an essential master transcription factor in hematopoietic development and plays important roles in immune functions. Although the gene regulatory mechanism of RUNX1 has been characterized extensively, the epigenetic role of RUNX1 remains unclear. Here, we demonstrate that RUNX1 contributes DNA demethylation in a binding site-directed manner in human hematopoietic cells. Overexpression analysis of RUNX1 showed the RUNX1-binding site-directed DNA demethylation. The RUNX1-mediated DNA demethylation was also observed in DNA replication-arrested cells, suggesting an involvement of active demethylation mechanism. Coimmunoprecipitation in hematopoietic cells showed physical interactions between RUNX1 and DNA demethylation machinery enzymes TET2, TET3, TDG, and GADD45. Further chromatin immunoprecipitation sequencing revealed colocalization of RUNX1 and TET2 in the same genomic regions, indicating recruitment of DNA demethylation machinery by RUNX1. Finally, methylome analysis revealed significant overrepresentation of RUNX1-binding sites at demethylated regions during hematopoietic development. Collectively, the present data provide evidence that RUNX1 contributes site specificity of DNA demethylation by recruitment of TET and other demethylation-related enzymes to its binding sites in hematopoietic cells.

Citing Articles

Hypomethylation of isoform A correlates with transcriptional expression and is associated with poor survival in acute myeloid leukemia.

Wu D, Qiu H, Xu J, Lin J, Qian J Front Immunol. 2025; 16:1490330.

PMID: 40034691 PMC: 11873079. DOI: 10.3389/fimmu.2025.1490330.

'Nomadic' Hematopoietic Stem Cells Navigate the Embryonic Landscape.

Narayan A, Hariom S, Mukherjee A, Das D, Nair A, Nelson E Stem Cell Rev Rep. 2025; .

PMID: 39786676 DOI: 10.1007/s12015-025-10843-6.

DNA Methylation Patterns Associated with Tinnitus in Young Adults-A Pilot Study.

Bhatt I, Raygoza Garay J, Torkamani A, Dias R J Assoc Res Otolaryngol. 2024; 25(5):507-523.

PMID: 39147981 PMC: 11528087. DOI: 10.1007/s10162-024-00961-2.

FLI1 is associated with regulation of DNA methylation and megakaryocytic differentiation in FPDMM caused by a RUNX1 transactivation domain mutation.

Tanaka Y, Nakanishi Y, Furuhata E, Nakada K, Maruyama R, Suzuki H Sci Rep. 2024; 14(1):14080.

PMID: 38890442 PMC: 11189521. DOI: 10.1038/s41598-024-64829-4.

Hematopoietic Transcription Factor RUNX1 is Essential for Promoting Macrophage-Myofibroblast Transition in Non-Small-Cell Lung Carcinoma.

Chiu-Tsun Tang P, Chan M, Chung J, Chan A, Zhang D, Li C Adv Sci (Weinh). 2023; 11(1):e2302203.

PMID: 37967345 PMC: 10767400. DOI: 10.1002/advs.202302203.

References

Reed-Inderbitzin E, Moreno-Miralles I, Vanden-Eynden S, Xie J, Lutterbach B, Durst-Goodwin K . RUNX1 associates with histone deacetylases and SUV39H1 to repress transcription. Oncogene. 2006; 25(42):5777-86. DOI: 10.1038/sj.onc.1209591. View

Huang G, Zhang P, Hirai H, Elf S, Yan X, Chen Z . PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis. Nat Genet. 2007; 40(1):51-60. DOI: 10.1038/ng.2007.7. View

Kundaje A, Meuleman W, Ernst J, Bilenky M, Yen A, Heravi-Moussavi A . Integrative analysis of 111 reference human epigenomes. Nature. 2015; 518(7539):317-30. PMC: 4530010. DOI: 10.1038/nature14248. View

Sandelin A, Alkema W, Engstrom P, Wasserman W, Lenhard B . JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 2003; 32(Database issue):D91-4. PMC: 308747. DOI: 10.1093/nar/gkh012. View

Schoenherr C, Levorse J, Tilghman S . CTCF maintains differential methylation at the Igf2/H19 locus. Nat Genet. 2002; 33(1):66-9. DOI: 10.1038/ng1057. View

Forrest A, Kawaji H, Rehli M, Baillie J, de Hoon M, Haberle V . A promoter-level mammalian expression atlas. Nature. 2014; 507(7493):462-70. PMC: 4529748. DOI: 10.1038/nature13182. View

Perez-Caballero D, Zang T, Ebrahimi A, McNatt M, Gregory D, Johnson M . Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell. 2009; 139(3):499-511. PMC: 2844890. DOI: 10.1016/j.cell.2009.08.039. View

Taniuchi I, Osato M, Egawa T, Sunshine M, Bae S, Komori T . Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell. 2002; 111(5):621-33. DOI: 10.1016/s0092-8674(02)01111-x. View

Lacaud G, Gore L, Kennedy M, Kouskoff V, Kingsley P, Hogan C . Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro. Blood. 2002; 100(2):458-66. DOI: 10.1182/blood-2001-12-0321. View

10.

Valinluck V, Sowers L . Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res. 2007; 67(3):946-50. DOI: 10.1158/0008-5472.CAN-06-3123. View

11.

Lohoff M, Mak T . Roles of interferon-regulatory factors in T-helper-cell differentiation. Nat Rev Immunol. 2005; 5(2):125-35. DOI: 10.1038/nri1552. View

12.

Nishida H, Suzuki T, Ookawa H, Tomaru Y, Hayashizaki Y . Comparative analysis of expression of histone H2a genes in mouse. BMC Genomics. 2005; 6:108. PMC: 1198228. DOI: 10.1186/1471-2164-6-108. View

13.

Jost J, Jost Y . Transient DNA demethylation in differentiating mouse myoblasts correlates with higher activity of 5-methyldeoxycytidine excision repair. J Biol Chem. 1994; 269(13):10040-3. View

14.

Takahashi A, Satake M, Yamaguchi-Iwai Y, Bae S, Lu J, Maruyama M . Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2. Blood. 1995; 86(2):607-16. View

15.

Goll M, Bestor T . Eukaryotic cytosine methyltransferases. Annu Rev Biochem. 2005; 74:481-514. DOI: 10.1146/annurev.biochem.74.010904.153721. View

16.

Kohli R, Zhang Y . TET enzymes, TDG and the dynamics of DNA demethylation. Nature. 2013; 502(7472):472-9. PMC: 4046508. DOI: 10.1038/nature12750. View

17.

Liddiard K, Hills R, Burnett A, Darley R, Tonks A . OGG1 is a novel prognostic indicator in acute myeloid leukaemia. Oncogene. 2009; 29(13):2005-12. DOI: 10.1038/onc.2009.462. View

18.

Guilhamon P, Eskandarpour M, Halai D, Wilson G, Feber A, Teschendorff A . Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2. Nat Commun. 2013; 4:2166. PMC: 3759038. DOI: 10.1038/ncomms3166. View

19.

Wang H, Maurano M, Qu H, Varley K, Gertz J, Pauli F . Widespread plasticity in CTCF occupancy linked to DNA methylation. Genome Res. 2012; 22(9):1680-8. PMC: 3431485. DOI: 10.1101/gr.136101.111. View

20.

Hashimoto H, Liu Y, Upadhyay A, Chang Y, Howerton S, Vertino P . Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation. Nucleic Acids Res. 2012; 40(11):4841-9. PMC: 3367191. DOI: 10.1093/nar/gks155. View